These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 15299077)
1. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Maglione JE; McGoldrick ET; Young LJ; Namba R; Gregg JP; Liu L; Moghanaki D; Ellies LG; Borowsky AD; Cardiff RD; MacLeod CL Mol Cancer Ther; 2004 Aug; 3(8):941-53. PubMed ID: 15299077 [TBL] [Abstract][Full Text] [Related]
2. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression. Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046 [TBL] [Abstract][Full Text] [Related]
3. Transgenic Polyoma middle-T mice model premalignant mammary disease. Maglione JE; Moghanaki D; Young LJ; Manner CK; Ellies LG; Joseph SO; Nicholson B; Cardiff RD; MacLeod CL Cancer Res; 2001 Nov; 61(22):8298-305. PubMed ID: 11719463 [TBL] [Abstract][Full Text] [Related]
4. Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase. Ellies LG; Fishman M; Hardison J; Kleeman J; Maglione JE; Manner CK; Cardiff RD; MacLeod CL Int J Cancer; 2003 Aug; 106(1):1-7. PubMed ID: 12794750 [TBL] [Abstract][Full Text] [Related]
5. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of mammary lesions represent molecular differences. Namba R; Maglione JE; Davis RR; Baron CA; Liu S; Carmack CE; Young LJ; Borowsky AD; Cardiff RD; Gregg JP BMC Cancer; 2006 Dec; 6():275. PubMed ID: 17147824 [TBL] [Abstract][Full Text] [Related]
8. PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide deficiency. Ellies LG Arch Oral Biol; 2003 Jun; 48(6):415-22. PubMed ID: 12749913 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells. Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487 [TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Namba R; Maglione JE; Young LJ; Borowsky AD; Cardiff RD; MacLeod CL; Gregg JP Mol Cancer Res; 2004 Aug; 2(8):453-63. PubMed ID: 15328372 [TBL] [Abstract][Full Text] [Related]
11. Mammary carcinoma behavior is programmed in the precancer stem cell. Damonte P; Hodgson JG; Chen JQ; Young LJ; Cardiff RD; Borowsky AD Breast Cancer Res; 2008; 10(3):R50. PubMed ID: 18522749 [TBL] [Abstract][Full Text] [Related]
12. Biological and genetic properties of the p53 null preneoplastic mammary epithelium. Medina D; Kittrell FS; Shepard A; Stephens LC; Jiang C; Lu J; Allred DC; McCarthy M; Ullrich RL FASEB J; 2002 Jun; 16(8):881-3. PubMed ID: 11967232 [TBL] [Abstract][Full Text] [Related]
13. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis. Zuo Y; Ulu A; Chang JT; Frost JA Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144 [TBL] [Abstract][Full Text] [Related]
14. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Guy CT; Muthuswamy SK; Cardiff RD; Soriano P; Muller WJ Genes Dev; 1994 Jan; 8(1):23-32. PubMed ID: 7507074 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer. Marcotte R; Muller WJ J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):323-35. PubMed ID: 18651209 [TBL] [Abstract][Full Text] [Related]
17. Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in mice. Zhang H; Kuang SQ; Liao L; Zhou S; Xu J Cancer Res; 2004 Oct; 64(19):7169-77. PubMed ID: 15466215 [TBL] [Abstract][Full Text] [Related]
18. Functional analysis of mouse keratin 8 in polyoma middle T-induced mammary gland tumours. Baribault H; Wilson-Heiner M; Muller W; Penner J; Bakhiet N Transgenic Res; 1997 Nov; 6(6):359-67. PubMed ID: 9423286 [TBL] [Abstract][Full Text] [Related]
19. The induction of uterine leiomyomas and mammary tumors in transgenic mice expressing polyomavirus (PyV) large T (LT) antigen is associated with the ability of PyV LT antigen to form specific complexes with retinoblastoma and CUTL1 family members. Webster MA; Martin-Soudant N; Nepveu A; Cardiff RD; Muller WJ Oncogene; 1998 Apr; 16(15):1963-72. PubMed ID: 9591780 [TBL] [Abstract][Full Text] [Related]
20. Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential. Drobysheva D; Smith BA; McDowell M; Guillen KP; Ekiz HA; Welm BE Breast Cancer Res; 2015 Oct; 17(1):132. PubMed ID: 26429062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]